Malignant Intracranial Neoplasm — Trials

Malignant Intracranial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

637 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 192
Recruiting: 110
Ph III recruiting: 4
Growth YoY: +6.3%
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (100)

clinicaltrialsPublishedShowing 51–87 of 87 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06012695	NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma	recruiting	Phase 1 / Phase 2	79	Novelwise Pharmaceutical CorporationINDUSTRY	1	Apr 29, 2026	clinicaltrials
NCT04689048	Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery	recruiting	Phase 1	20	Baptist Health South FloridaOTHER	1	Apr 22, 2026	clinicaltrials